DK302887A - Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel - Google Patents

Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel

Info

Publication number
DK302887A
DK302887A DK302887A DK302887A DK302887A DK 302887 A DK302887 A DK 302887A DK 302887 A DK302887 A DK 302887A DK 302887 A DK302887 A DK 302887A DK 302887 A DK302887 A DK 302887A
Authority
DK
Denmark
Prior art keywords
tumornecrose
alfa
factor
preparation
infective medicine
Prior art date
Application number
DK302887A
Other languages
Danish (da)
English (en)
Other versions
DK302887D0 (da
Inventor
Michael Angelo Palladino
Arthur J Ammann
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK302887D0 publication Critical patent/DK302887D0/da
Publication of DK302887A publication Critical patent/DK302887A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK302887A 1986-06-16 1987-06-15 Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel DK302887A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87473686A 1986-06-16 1986-06-16
US5393887A 1987-05-22 1987-05-22

Publications (2)

Publication Number Publication Date
DK302887D0 DK302887D0 (da) 1987-06-15
DK302887A true DK302887A (da) 1987-12-17

Family

ID=26732412

Family Applications (1)

Application Number Title Priority Date Filing Date
DK302887A DK302887A (da) 1986-06-16 1987-06-15 Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel

Country Status (8)

Country Link
EP (1) EP0250192A3 (de)
JP (1) JPH07100662B2 (de)
AU (1) AU598817B2 (de)
DK (1) DK302887A (de)
IL (1) IL82862A0 (de)
NZ (1) NZ220686A (de)
PH (1) PH26613A (de)
PT (1) PT85076B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219027A (en) * 1986-01-24 1989-09-27 Genentech Inc Antiviral composition containing interferon tumour necrosis factor and/or lymphotoxin
DE3613166A1 (de) * 1986-04-18 1987-10-29 Basf Ag Verwendung von tnf zur herstellung von arzneimitteln
US5322699A (en) * 1991-02-04 1994-06-21 The Rockefeller University Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3472793D1 (en) * 1983-12-26 1988-08-25 Asahi Chemical Ind A novel physiologically active polypeptide
DE3423234A1 (de) * 1984-06-23 1986-02-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Synergistische mischungen von interferonen und tumor-nekrose-faktor
GR851626B (de) * 1984-07-05 1985-11-26 Genentech Inc
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines

Also Published As

Publication number Publication date
EP0250192A2 (de) 1987-12-23
NZ220686A (en) 1990-02-26
AU7422387A (en) 1987-12-17
AU598817B2 (en) 1990-07-05
PT85076A (en) 1987-07-01
PH26613A (en) 1992-08-19
JPS6354327A (ja) 1988-03-08
IL82862A0 (en) 1987-12-20
JPH07100662B2 (ja) 1995-11-01
PT85076B (pt) 1990-07-31
EP0250192A3 (de) 1988-02-10
DK302887D0 (da) 1987-06-15

Similar Documents

Publication Publication Date Title
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
DK263288D0 (da) Farmaceutisk praeparat af cefuroxim-axetil
DK195988D0 (da) Farmaceutisk praeparat indeholdende mikrokapsler
DK158770C (da) Anvendelse af paroxetin til fremstilling af medikament mod fedme
DK404187A (da) Fremgangsmaade til fremstilling af thiazolderivater
DK153387A (da) Fremgangsmaade til fremstilling af laegemiddel-adsorbater
DK119086A (da) Fremgangsmaade til fremstilling af oligonucleotider
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
DK473088D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK473288D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK28788A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK573888D0 (da) Fremgangsmaade til fremstilling af paramunitetsinducere
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK302887A (da) Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel
DK533287D0 (da) Fremgangsmaade til fremstilling af azetidinoner
DK184687D0 (da) Fremgangsmaade til fremstilling af diacetonesorbose
DK258886A (da) Fremgangsmaade til fremstilling af alkyloxiraner
DK509986D0 (da) Fremgangsmaade til fremstilling af aryl-cyanamider
DK68790A (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
DK473188D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK162789D0 (da) Fremgangsmaade til fremstilling af alkalimetalphenylpyruvat
DK234687D0 (da) Fremgangsmaade til fremstilling af ribitylxylidin
DK646188A (da) Fremgangsmaade til fremstilling af halogenalkyllactamer
DK390887D0 (da) Fremgangsmaade til fremstilling af 7alfa-acetylthiosteroider
DK61091D0 (da) Fremgangsmaade til fremstilling af 4-phenylpiperidinderivater

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment